Cargando…

Characteristic clinical features of adipsic hypernatremia patients with subfornical organ-targeting antibody

Adipsic hypernatremia is a rare disease presenting as persistent hypernatremia with disturbance of thirst regulation and hypothalamic dysfunction. As a result of congenital disease, tumors, or inflammation, most cases are accompanied by structural abnormalities in the hypothalamic-pituitary area. Wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura-Utsunomiya, Akari, Hiyama, Takeshi Y., Okada, Satoshi, Noda, Masaharu, Kobayashi, Masao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society for Pediatric Endocrinology 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627220/
https://www.ncbi.nlm.nih.gov/pubmed/29026268
http://dx.doi.org/10.1297/cpe.26.197
_version_ 1783268673104904192
author Nakamura-Utsunomiya, Akari
Hiyama, Takeshi Y.
Okada, Satoshi
Noda, Masaharu
Kobayashi, Masao
author_facet Nakamura-Utsunomiya, Akari
Hiyama, Takeshi Y.
Okada, Satoshi
Noda, Masaharu
Kobayashi, Masao
author_sort Nakamura-Utsunomiya, Akari
collection PubMed
description Adipsic hypernatremia is a rare disease presenting as persistent hypernatremia with disturbance of thirst regulation and hypothalamic dysfunction. As a result of congenital disease, tumors, or inflammation, most cases are accompanied by structural abnormalities in the hypothalamic-pituitary area. While cases with no hypothalamic-pituitary structural lesion have been reported, their etiology has not been elucidated. Recently, we reported three patients with adipsic hypernatremia whose serum-derived immunoglobulin (Ig) specifically reacted with mouse subfornical organ (SFO) tissue. As one of the circumventricular organs (CVOs) that form a sensory interface between the blood and brain, the SFO is a critical site for generating physiological responses to dehydration and hypernatremia. Intravenous injection of the patient’s Ig fraction induced hypernatremia in mice, along with inflammation and apoptosis in the SFO. These results support a new autoimmunity-related mechanism for inducing adipsic hypernatremia without demonstrable hypothalamic-pituitary structural lesions. In this review, we aim to highlight the characteristic clinical features of these patients, in addition to etiological mechanisms related to SFO function. These findings may be useful for diagnosing adipsic hypernatremia caused by an autoimmune response to the SFO, and support development of new strategies for prevention and treatment.
format Online
Article
Text
id pubmed-5627220
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher The Japanese Society for Pediatric Endocrinology
record_format MEDLINE/PubMed
spelling pubmed-56272202017-10-12 Characteristic clinical features of adipsic hypernatremia patients with subfornical organ-targeting antibody Nakamura-Utsunomiya, Akari Hiyama, Takeshi Y. Okada, Satoshi Noda, Masaharu Kobayashi, Masao Clin Pediatr Endocrinol Review Adipsic hypernatremia is a rare disease presenting as persistent hypernatremia with disturbance of thirst regulation and hypothalamic dysfunction. As a result of congenital disease, tumors, or inflammation, most cases are accompanied by structural abnormalities in the hypothalamic-pituitary area. While cases with no hypothalamic-pituitary structural lesion have been reported, their etiology has not been elucidated. Recently, we reported three patients with adipsic hypernatremia whose serum-derived immunoglobulin (Ig) specifically reacted with mouse subfornical organ (SFO) tissue. As one of the circumventricular organs (CVOs) that form a sensory interface between the blood and brain, the SFO is a critical site for generating physiological responses to dehydration and hypernatremia. Intravenous injection of the patient’s Ig fraction induced hypernatremia in mice, along with inflammation and apoptosis in the SFO. These results support a new autoimmunity-related mechanism for inducing adipsic hypernatremia without demonstrable hypothalamic-pituitary structural lesions. In this review, we aim to highlight the characteristic clinical features of these patients, in addition to etiological mechanisms related to SFO function. These findings may be useful for diagnosing adipsic hypernatremia caused by an autoimmune response to the SFO, and support development of new strategies for prevention and treatment. The Japanese Society for Pediatric Endocrinology 2017-09-28 2017 /pmc/articles/PMC5627220/ /pubmed/29026268 http://dx.doi.org/10.1297/cpe.26.197 Text en ©2017 The Japanese Society for Pediatric Endocrinology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. (CC-BY-NC-ND 4.0: http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review
Nakamura-Utsunomiya, Akari
Hiyama, Takeshi Y.
Okada, Satoshi
Noda, Masaharu
Kobayashi, Masao
Characteristic clinical features of adipsic hypernatremia patients with subfornical organ-targeting antibody
title Characteristic clinical features of adipsic hypernatremia patients with subfornical organ-targeting antibody
title_full Characteristic clinical features of adipsic hypernatremia patients with subfornical organ-targeting antibody
title_fullStr Characteristic clinical features of adipsic hypernatremia patients with subfornical organ-targeting antibody
title_full_unstemmed Characteristic clinical features of adipsic hypernatremia patients with subfornical organ-targeting antibody
title_short Characteristic clinical features of adipsic hypernatremia patients with subfornical organ-targeting antibody
title_sort characteristic clinical features of adipsic hypernatremia patients with subfornical organ-targeting antibody
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627220/
https://www.ncbi.nlm.nih.gov/pubmed/29026268
http://dx.doi.org/10.1297/cpe.26.197
work_keys_str_mv AT nakamurautsunomiyaakari characteristicclinicalfeaturesofadipsichypernatremiapatientswithsubfornicalorgantargetingantibody
AT hiyamatakeshiy characteristicclinicalfeaturesofadipsichypernatremiapatientswithsubfornicalorgantargetingantibody
AT okadasatoshi characteristicclinicalfeaturesofadipsichypernatremiapatientswithsubfornicalorgantargetingantibody
AT nodamasaharu characteristicclinicalfeaturesofadipsichypernatremiapatientswithsubfornicalorgantargetingantibody
AT kobayashimasao characteristicclinicalfeaturesofadipsichypernatremiapatientswithsubfornicalorgantargetingantibody